|
Multi-institutional analysis of high-risk prostate cancer patients treated with stereotactic body radiotherapy. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma |
|
|
Other Relationship - International Journal of Radiation Oncology Biology Physics |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Gene Sciences |
Consulting or Advisory Role - Gene Sciences; Gene Sciences; PRogenics; PRogenics |
Research Funding - Janssen Scientific Affairs; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems |
Patents, Royalties, Other Intellectual Property - I am listed as inventor on patents related to PyIm polyamides that have been licensed by Gene Sciences |
|
|
|
Consulting or Advisory Role - Viewray |
Research Funding - ViewRay |
Travel, Accommodations, Expenses - Viewray |
|
|
Employment - Varian Medical Systems |
Stock and Other Ownership Interests - Varian Medical Systems |
Travel, Accommodations, Expenses - Varian Medical Systems; Varian Medical Systems |
|
|
Honoraria - Varian Medical Systems; ViewRay; ViewRay |
Consulting or Advisory Role - Janssen |